Cathie Wood Pfizer Inc Transaction History

Ark Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	BUY	$26.13 - $33.94 $932,240 - $1.21 Million	35,677 Added 7.69%	499,757 $14.4 Million
Q3 2023 Oct 18, 2023	SELL	$32.09 - $37.51 $48,808 - $57,052	-1,521 Reduced 0.33%	464,080 $15.4 Million
Q2 2023 Jul 10, 2023	SELL	$36.12 - $41.79 $693,106 - $801,908	-19,189 Reduced 3.96%	465,601 $17.1 Million
Q1 2023 Apr 17, 2023	SELL	$39.39 - $51.28 $266,473 - $346,909	-6,765 Reduced 1.38%	484,790 $19.8 Million
Q4 2022 Jan 24, 2023	SELL	$41.75 - $54.5 $1.72 Million - $2.25 Million	-41,257 Reduced 7.74%	491,555 $0
Q3 2022 Oct 17, 2022	SELL	$43.76 - $53.42 $8.81 Million - $10.8 Million	-201,353 Reduced 27.43%	532,812 $23.3 Million
Q2 2022 Jul 11, 2022	SELL	$46.53 - $55.17 $1.2 Million - $1.42 Million	-25,766 Reduced 3.39%	734,165 $38.9 Million
Q1 2022 Apr 19, 2022	SELL	$45.75 - $56.69 $8.41 Million - $10.4 Million	-183,918 Reduced 19.49%	759,931 $39.3 Million
Q4 2021 Jan 28, 2022	SELL	$41.32 - $61.25 $52.6 Million - $78 Million	-1,273,820 Reduced 57.44%	943,849 $55.7 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $87 Million - $112 Million	2,217,669 New	2,217,669 $95.4 Million

3,267

3.73B

74.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.